292 related articles for article (PubMed ID: 16224252)
21. Systemic sclerosis-associated interstitial lung disease.
Perelas A; Silver RM; Arrossi AV; Highland KB
Lancet Respir Med; 2020 Mar; 8(3):304-320. PubMed ID: 32113575
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I is partially responsible for fibroblast proliferation induced by bronchoalveolar lavage fluid from patients with systemic sclerosis.
Harrison NK; Cambrey AD; Myers AR; Southcott AM; Black CM; du Bois RM; Laurent GJ; McAnulty RJ
Clin Sci (Lond); 1994 Feb; 86(2):141-8. PubMed ID: 8143424
[TBL] [Abstract][Full Text] [Related]
23. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
24. [New developments in systemic sclerosis-associated interstitial lung disease].
Humair G; Daccord C; Beigelman-Aubry C; Lazor R
Rev Med Suisse; 2020 Nov; 16(715):2218-2223. PubMed ID: 33206479
[TBL] [Abstract][Full Text] [Related]
25. Interstitial lung disease in systemic sclerosis.
Renzoni EA
Monaldi Arch Chest Dis; 2007 Dec; 67(4):217-28. PubMed ID: 18309700
[TBL] [Abstract][Full Text] [Related]
26. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
[TBL] [Abstract][Full Text] [Related]
27. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
28. Interstitial lung disease points to consider for clinical trials in systemic sclerosis.
Khanna D; Seibold J; Goldin J; Tashkin DP; Furst DE; Wells A
Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v27-v32. PubMed ID: 28992174
[TBL] [Abstract][Full Text] [Related]
29. Interstitial lung disease in systemic sclerosis.
Kaloudi O; Miniati I; Alari S; Matucci-Cerinic M
Intern Emerg Med; 2007 Dec; 2(4):250-5. PubMed ID: 18172592
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.
Volkmann ER; Tashkin DP
Ann Am Thorac Soc; 2016 Nov; 13(11):2045-2056. PubMed ID: 27560196
[TBL] [Abstract][Full Text] [Related]
31. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
[TBL] [Abstract][Full Text] [Related]
32. [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].
Marie I; Lévesque H; Dominique S; Hatron PY; Michon-Pasturel U; Remy-Jardin M; Courtois H
Rev Med Interne; 1999 Nov; 20(11):1004-16. PubMed ID: 10586439
[TBL] [Abstract][Full Text] [Related]
33. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
[TBL] [Abstract][Full Text] [Related]
34. Interstitial lung disease of systemic sclerosis.
Silver RM
Int Rev Immunol; 1995; 12(2-4):281-91. PubMed ID: 7650424
[TBL] [Abstract][Full Text] [Related]
35. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.
Numajiri H; Yoshizaki A; Ebata S; Fukasawa T; Yamashita T; Takahashi T; Taniguchi T; Asano Y; Sato S
J Dermatol; 2018 Jun; 45(6):e140-e141. PubMed ID: 29265579
[No Abstract] [Full Text] [Related]
37. Progression of interstitial lung disease upon overlapping of systemic sclerosis with polymyositis.
Ishiguro T; Yasui M; Takato H; Kimura H; Katayama N; Kasahara K; Fujimura M
Intern Med; 2007; 46(15):1237-41. PubMed ID: 17675776
[TBL] [Abstract][Full Text] [Related]
38. Systemic sclerosis interstitial lung disease: unmet needs and potential solutions.
Liakouli V; Ciancio A; Del Galdo F; Giacomelli R; Ciccia F
Nat Rev Rheumatol; 2024 Jan; 20(1):21-32. PubMed ID: 37923862
[TBL] [Abstract][Full Text] [Related]
39. Nonspecific interstitial pneumonia and systemic sclerosis.
King TE
Am J Respir Crit Care Med; 2002 Jun; 165(12):1578-9. PubMed ID: 12070054
[No Abstract] [Full Text] [Related]
40. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.
Khanna D; Brown KK; Clements PJ; Elashoff R; Furst DE; Goldin J; Seibold JR; Silver RM; Tashkin DP; Wells AU
Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S55-62. PubMed ID: 20576216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
